Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2025 Earnings Call Transcript February 25, 2026
Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.86 EPS, expectations were $-1.56.
Operator: Good day, and thank you for standing by. Welcome to Revolution Medicines Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today,...
